CompletedPhase 3NCT01757184
Acid Lipase Replacement Investigating Safety and Efficacy (ARISE) in Participants With Lysosomal Acid Lipase Deficiency
Studying Cholesteryl ester storage disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Principal Investigator
- Florian Abel, MDAlexion Pharmaceuticals, Inc.
- Intervention
- Sebelipase Alfa(drug)
- Enrollment
- 66 enrolled
- Eligibility
- 4 years · All sexes
- Timeline
- 2013 – 2018
Study locations (30)
- Tucson, Arizona, United States
- Palo Alto, California, United States
- San Francisco, California, United States
- Wilmington, Delaware, United States
- Chicago, Illinois, United States
- Boston, Massachusetts, United States
- Buffalo, New York, United States
- Manhasset, New York, United States
- New York, New York, United States
- Cincinnati, Ohio, United States
- Philadelphia, Pennsylvania, United States
- Córdoba, Argentina
- Brisbane, Australia
- New Lambton, Australia
- Parkville, Australia
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01757184 on ClinicalTrials.gov